Author:
Rosell Rafael,Fossella Frank,Milas Luka
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference48 articles.
1. Schiller JH, Harrington D, Sander A et al. A randomized phase III trial of four chemotherapy regimens in advanced NSCLC, Proc Am Soc Clin Oncol 2000;19:abstract A-2.
2. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: a Southwest Oncology Group Trial;Kelly;J. Clin. Oncol.,2001
3. Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial;Georgoulias;Lancet,2001
4. Neoadjuvant chemotherapy with docetaxel (DOC, taxotere) and cisplatin (CIS) in patients (pts) with non-small cell lung cancer (NSCLC), stage IIIA, N2 is highly active with few toxicities;Betticher;Proc. Am. Soc. Clin. Oncol.,1999
5. ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy;Metzger;J. Clin. Oncol.,1998
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献